Business Description
Medifast Inc
NAICS : 812199
SIC : 7299
ISIN : US58470H1014
Share Class Description:
FRA:MDF: Ordinary SharesTotal Employee Number:
380Description
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 10.49 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -8.95 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 4.19 | |||||
Beneish M-Score | -3.49 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -37.2 | |||||
3-Year EBITDA Growth Rate | -94.4 | |||||
3-Year FCF Growth Rate | -80.7 | |||||
3-Year Book Growth Rate | 8.3 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 13.77 | |||||
9-Day RSI | 24.91 | |||||
14-Day RSI | 33.1 | |||||
3-1 Month Momentum % | 35.8 | |||||
6-1 Month Momentum % | 18.99 | |||||
12-1 Month Momentum % | -3.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.8 | |||||
Quick Ratio | 4.3 | |||||
Cash Ratio | 4 | |||||
Days Inventory | 94.88 | |||||
Days Payable | 131.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.4 | |||||
Shareholder Yield % | 3.98 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 70.12 | |||||
Operating Margin % | -4.69 | |||||
Net Margin % | -5.79 | |||||
EBITDA Margin % | -0.52 | |||||
FCF Margin % | -0.45 | |||||
OCF Margin % | 1.04 | |||||
ROE % | -9.64 | |||||
ROA % | -7.6 | |||||
ROIC % | -26.04 | |||||
3-Year ROIIC % | 286.45 | |||||
ROC (Joel Greenblatt) % | -37.68 | |||||
ROCE % | -7.53 | |||||
Years of Profitability over Past 10-Year | 9 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 51.29 | |||||
Shiller PE Ratio | 1.52 | |||||
PS Ratio | 0.33 | |||||
PB Ratio | 0.59 | |||||
Price-to-Tangible-Book | 0.59 | |||||
Price-to-Operating-Cash-Flow | 30.82 | |||||
EV-to-EBIT | 2.22 | |||||
EV-to-EBITDA | 19.99 | |||||
EV-to-Forward-EBITDA | 8.33 | |||||
EV-to-Revenue | -0.1 | |||||
EV-to-Forward-Revenue | 1.47 | |||||
EV-to-FCF | 24.46 | |||||
Price-to-GF-Value | 1.2 | |||||
Price-to-Projected-FCF | 0.12 | |||||
Price-to-Median-PS-Value | 0.21 | |||||
| Price-to-Net-Current-Asset-Value | 0.78 | |||||
| Price-to-Net-Cash | 1.02 | |||||
Earnings Yield (Greenblatt) % | 45.05 | |||||
FCF Yield % | -1.26 | |||||
Forward Rate of Return (Yacktman) % | 2.4 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Medifast Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 297.602 | ||
| EPS (TTM) (€) | -1.561 | ||
| Beta | 1.1638 | ||
| 3-Year Sharpe Ratio | -1.61 | ||
| 3-Year Sortino Ratio | -1.63 | ||
| Volatility % | 27.56 | ||
| 14-Day RSI | 33.1 | ||
| 14-Day ATR (€) | 0.380518 | ||
| 20-Day SMA (€) | 9.7235 | ||
| 12-1 Month Momentum % | -3.18 | ||
| 52-Week Range (€) | 7.67 - 12.77 | ||
| Shares Outstanding (Mil) | 11.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medifast Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medifast Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-03 16:30 | In 130 days | ||
| Third quarter earnings results for 2026 | 2026-11-03 | In 129 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-04 16:30 | In 39 days | ||
| Second quarter earnings results for 2026 | 2026-08-04 | In 38 days | ||
| General meeting for 2026 | 2026-05-19 | 10.24 (-2.29%) | ||
| First quarter earnings conference call for 2026 | 2026-05-04 16:30 | 8.69 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-04 | 8.69 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-17 16:30 | 8.42 (-5.26%) | ||
| Annual report for 2025 | 2026-02-17 | 8.42 (-5.26%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-17 | 8.42 (-5.26%) |
Show
Entries
Medifast Inc Frequently Asked Questions
What is Medifast Inc(FRA:MDF)'s stock price today?
The current price of FRA:MDF is €8.44. The 52 week high of FRA:MDF is €12.77 and 52 week low is €7.67.
When is next earnings date of Medifast Inc(FRA:MDF)?
The next earnings date of Medifast Inc(FRA:MDF) is 2026-08-04 Est..
Does Medifast Inc(FRA:MDF) pay dividends? If so, how much?
Medifast Inc(FRA:MDF) does not pay dividend.
Press Release
Articles on Medifast Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers